Showing results 1 to 4 of 4
Title | Author(s) | Issue Date | |
---|---|---|---|
Checkpoint Kinase 2 Inhibition Can Reverse Tamoxifen Resistance in ER-Positive Breast Cancer Journal:International Journal of Molecular Sciences | 2022 | ||
Combined use of Ivabradine and Olaparib as a novel therapeutic strategy for triple-negative breast cancer Proceeding/Conference:The Virtual New Zealand Breast Cancer Symposium, 2021 | 2021 | ||
Targeting androgen receptor in BQ323636.1 overexpressing ER+ breast cancer to overcome aromatase inhibitor resistance Proceeding/Conference:The Virtual New Zealand Breast Cancer Symposium, 2021 | 2021 | ||
Targeting CHK2 to reverse tamoxifen resistance by reducing BQ323636.1 in ER-positive breast cancer Proceeding/Conference:The Virtual New Zealand Breast Cancer Symposium, 2021 | 2021 |